In a mouse model of acute myeloid leukemia (AML), blocking glutamine metabolism with a glutaminase inhibitor (CB-839) significantly impaired antioxidant glutathione production in multiple types of AML, leading to an increase in mitochondrial reactive oxygen species (mitoROS) and apoptosis. This evidence concerns the gene GLS and acute myeloid leukemia.